US Patent

US11141540 — Syringe devices

Method of Use · Assigned to Adamis Pharmaceuticals Corp · Expires 2036-10-20 · 10y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects syringe devices that house a therapeutic dose of at least one drug, including a mechanism for moving a stopper without user contact.

USPTO Abstract

Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug and a stopper. The syringe is housed and/or placed in an encasement. The plunger assembly can include a plunger, an actuator, and a spacer, wherein the plunger assembly is configured to move the stopper a predetermined distance without a user touching the plunger. Methods of assembling and using the syringe devices are also described.

Drugs covered by this patent

Epipen (epinephrine) · Pfizer Inc.

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3379`	—	Epipen
`U-3379`	—	Epipen

Patent Metadata

Patent number: US11141540
Jurisdiction: US
Classification: Method of Use
Expires: 2036-10-20
Drug substance claim: No
Drug product claim: Yes
Assignee: Adamis Pharmaceuticals Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.